Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3211-3229
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3211
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3211
Figure 3 Weiwei Decoction improves gastric mucosal histological lesions.
A: Timeline of the animal experiments design for Weiwei Decoction treatment; B: Representative hematoxylin and eosin-stained images of the gastric mucosa in each group (n = 3). Vacuolation changes (orange arrow), pyknotic and hyperchromatic nuclei (blue arrow); C: Representative Alcian blue-Periodic acid-Schiff-stained images of the gastric mucosa in each group (n = 3). Blue-stained cavities (yellow arrow). Scale bar: 100 μm. WWD: Weiwei Decoction; FA: Folic acid; HE: Hematoxylin and eosin; AB-PAS: Alcian blue-Periodic acid-Schiff.
- Citation: Zhou DS, Zhang WJ, Song SY, Hong XX, Yang WQ, Li JJ, Xu JQ, Kang JY, Cai TT, Xu YF, Guo SJ, Pan HF, Li HW. Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway. World J Gastrointest Oncol 2024; 16(7): 3211-3229
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3211.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3211